Skip to main content

Table 2 Antibiotic susceptibility patterns of V. fluvialis strains

From: The virulence phenotypes and molecular epidemiological characteristics of Vibrio fluvialis in China

Antibiotic Breakpoints (mg/ml) Resistance Sensitivity
   R (%) I (%) S (%)
Ampicillin S<=8 I=16 R>=32a 12 (27.3) 8 (18.2) 24 (54.5)
Amoxicillin/Clavulanic acid S<=8/4 I=16/8 R>=32/16b 10 (22.7) 7 (15.9) 27 (61.4)
Cefotaxime S<=1 I=2 R>=4b 1 (2.3) 6 (13.6) 37 (84.1)
Ceftriaxone S<=1 I=2 R>=4b 1 (2.3) 6 (13.6) 37 (84.1)
Ceftazidime S<=4 I=8 R>=16b 0 (0) 0 (0) 44 (100)
Chloramphenicol S<=8 I=16 R>=32a 0 (0) 0 (0) 44 (100)
Ciprofloxacin S<=1 I=2 R>=4b 0 (0) 0 (0) 44 (100)
Gentamicin S<=4 I=8 R>=16b 0 (0) 0 (0) 44 (100)
Nalidixic acid S<=16 R>=32b 0 (0) - 44 (100)
Streptomycin S<16 R>=16d 1 (2.3) - 43 (97.7)
Sulfamethoxazole S<=256 R>=512a 11 (25.0) - 33 (75.0)
Trimethoprim S<=8 R>=16b 0 (0) - 44 (100)
Co-trimoxazole S<=2/38 R>=4/76a 0 (0) - 44 (100)
Tetracycline S<=4 I=8 R>=16a 1 (2.3) 0 (0) 43 (97.7)
Azithromycin S<=2 I=4 R>=8c 12 (27.3) 5 (11.4) 27 (61.3)
  1. aBreakpoints are based on the CLSI standards for V. cholerae.
  2. bBreakpoints refer to the CLSI criteria for Enterobacteriaceae.
  3. cBreakpoint is based on the CLSI standards for C. jejuni.
  4. dBreakpoint refer to the reference [61].
  5. R, resistance; I, intermediate; S, sensitivity.